Professional Documents
Culture Documents
Medical-Surgical Nursing
Certification Review
CMSRN Exam
GI 19% (36-40)
Pulmonary 19% (36-40)
Cardiovascular 15% (28-32)
Diabetes/Other endocrine 15% (28-32)
Renal/GU-12%(22-29)
Musculoskeletal/Neuro 11%
(20-24)
Hematological / Immune /
Integumentary 9% (16-20)
Publications to review
10
11
12
Stress Reduction
13
14
16
17
18
Fluid
Intracellular
Body water
Extracellular
Body water
19
Electrolytes
Same electrolytes in
intracellular space as
in extracellular space
Always measure
extracellular space
20
Sodium
21
Hyponatremia
True
Hypernatremia
Dry tissue
Treatment replace fluids
23
Potassium
24
Hyperkalemia
25
Hypokalemia
flaccidity
Treatment potassium supplements
IV
Oral
26
Calcium
27
Hypercalcemia
Sedation
Treatment
28
Hypocalcemia
29
Phosphate
30
Magnesium
Hypermagnesemia
Usually poor renal excretion
Muscular depression
Hypomagnesemia
Hyperactive
31
Serum Osmolality
32
IV Fluids
D5LR, D5NS
NS, LR
NS
33
34
A. Hypertonic
B. Isotonic
C. Hypotonic
D. Colloidal
35
36
37
38
Immune System
Leukocytes
A. Granulocytes
1. Neutrophils first line of
defense against bacteria
2. Eosinophils phagocytize
antigen-antibody complexes
3. Basophils- contain
histamine and heparin
39
Immune System
B. Nongranulocytes
1) Monocytes phagocytize
bacteria
2) Lymphocytes provide
immunity against foreign
invaders including transplants
C. Immune Response
1) Humoral B lymphocytes,
memory
2) Cellular T lymphocytes,
foreign invaders
40
Compromised
Immune System
Steroids
suppression of system
Chemotherapy
41
Acquired Immune
Deficiency Syndrome
In 2009
33.3 million people worldwide living
with AIDS
2.6 million new infections this year
Women and those 15-24 accounted for
50% of infections
Project that by 2012 100 million people
will be infected
42
Transmission of AIDS
Blood
Semen
Vaginal fluids
Breast milk
Transplacental ?
Transmitted even when asymptomatic
43
Pathophysiology
44
CD 4 Classification of AIDS
Category I:
Category III:
45
46
Treatment of AIDS
Prevention
Optimal treatment includes combination of
at least 3 drugs, often referred to as
HAART
Reverse transcriptase inhibitors
Protease inhibitors
Fusion inhibitors
47
Hematologic System
49
Lymphocytes:
T-lymphocytes-react against foreign or
abnormal cells
B-lymphocytes- becomes antibodies when
exposed to something seen as a long term
threat
50
Assessment
History
Objective information
Physical
assessment
Diagnostic studies
51
Hematologic concerns
Anemia
Blood loss, Hemolytic
Sickle cell
Iron deficiency
Pernicious
Disseminated Intravascular coagulation
Hodgkins
52
53
A.
B.
C.
D.
54
Cardiovascular system
55
56
57
58
59
CO=HR
SV
Stroke
volume
Preload
Afterload
Contractility
Heart Rate
Impact of the ANS
60
Assessment:
Nursing History
Past medical
Diet
Medication
Pain
Edema
Other
61
Chest Pain
Description?
Location?
Does it radiate?
What causes it?
What causes it worse?
What makes it better?
62
Physical Assessment
Inspection
Edema, skin assessment, hair
growth
Palpation
Peripheral pulses, PMI
63
Heart sounds
Normal
S1
S2
Abnormal
S3 lub DUB dub
S4 lub dub DUB
Murmurs
Friction rub
64
Diagnostic studies
Diagnostic procedures
Electrocardiogram
Electrophysiology
Echocardiography
Stress test
Doppler Ultrasound
Cardiac Catheterization
66
Coronary
Arterial
Thrombosis
Non-ST-Elevation
MI
STElevation MI
Sudden Death
67
68
Morphine
Beta blockers
ACE inhibitors
Calcium blockers
69
Salicylates: Aspirin
ADP-receptor inhibitors: Clopidogrel
Glycoprotein(GP) Iib-IIIa receptor antagonists
Heparin-unfractionated heparin (UFH)
Low- Molecular weight heparins (LMWH) with
UA/NSTEMI indications
Enoxaparin
Dalteparin
Direct- acting Antithrombins
Bivalirudin
Argatrobran
Lepirudin
70
CV Conditions
CHF
Diuretics,
Blockers
BNP- Brain Naturetic Peptide
Hypertension
Highest Risk: African American males in
southeast United States
Weight loss- diet management; exercise,
Diuretics, Ace inhibitors, Beta blockers,
Angiotensin 2 receptor blockers
71
CV conditions
Chronic Peripheral Circulatory Disease
Arterial(
73
Anxiety reaction
Cardiogenic shock
Medication overdose
Pulmonary edema
74
75
76
Cancer
Etiologic factors
Chemicals
Radiation
Viruses
Host-related
77
Cancer Prevention
Age
Sex
Geographical
location
Racial or ethnic
origin
Familial tendency
Environmental
Lifestyle
Tobacco use
Diet
Alcohol
Occupational risks
Biological risks
Iatrogenic risks
Psychosocial
78
79
Therapeutic modalities
80
2.
3.
4.
A.
B.
C.
D.
82
83
Gastrointestinal system
84
Objective Assessment
Diagnostic Studies
87
Liver Disease
treatment-paracentesis, Transjugular
intra-hepatic Porto-systemic shunting (TIPS),
organ transplant
Nursing interventions: Monitor for bleeding,
albumin, B vitamin levels, serum ammonia;
treat alcoholism (refer to rehab); teach
avoidance of hepatotoxic substances and use
of OTC meds; control ammonia related
encephalopathy-neomycin, lactulose, reduced
protein intake
88
Esophageal varices
89
Viral Hepatitis
Transmission
A-
Medical treatment
Hepatitis
90
91
Bowel disease
92
93
Bowel Disease
Obstruction
94
Colon Cancer
95
Pancreatitis
96
97
Interventions:
Assess
98
Antibiotics
Histamine 2 blockers
proton pump inhibitors
Barrier medications
99
Peritonitis
Nursing assessment
Monitor VS, WBCs, assess pain level,
assess firmness of the abdomen(rebound
tenderness)
Treatment:
Antibiotics(
intraperitoneal in peritoneal
dialysis patient)
Pain management
Antiemetics PRN
100
A. Hypomagnesemia
B. Increased ammonia levels
C. Decreased albumin levels
D. Poor lymphatic system
101
102
103
Nutrition
Essential for adequate functioning of all
body systems
104